Paper41753631
Beyond Antibiotics: Therapeutic Strategies Utilizing Probiotics and Bacteriophages Against Drug-Resistant Staphylococcus aureus.
Zhao M and 9 others. Microorganisms, 2026. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Beyond Antibiotics: Therapeutic Strategies Utilizing Probiotics and Bacteriophages Against Drug-Resistant Staphylococcus aureus. Papers, record 41753631. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41753631
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Beyond Antibiotics: Therapeutic Strategies Utilizing Probiotics and Bacteriophages Against Drug-Resistant Staphylococcus aureus.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2025A04J4149 | Science and Technology Projects of Guangzhou | PubMed |
Source PubMed
References161
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32,580,955 | 12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study. | Br J Ophthalmol | 2021 | https://conductscience.org/library/papers/32580955 | PubMed |
| 2 | 30,659,503 | Lactobacillus plantarum USM8613 Aids in Wound Healing and Suppresses Staphylococcus aureus Infection at Wound Sites. | Probiotics Antimicrob Proteins | 2020 | https://conductscience.org/library/papers/30659503 | PubMed |
| 3 | 35,052,963 | Current Status of Staphylococcal Cassette Chromosome mec (SCCmec). | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/35052963 | PubMed |
| 4 | 37,760,659 | Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA): An Updated Review. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37760659 | PubMed |
| 5 | 25,384,670 | The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors. | Nat Commun | 2014 | https://conductscience.org/library/papers/25384670 | PubMed |
| 6 | 12,491,202 | Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. | Clin Infect Dis | 2003 | https://conductscience.org/library/papers/12491202 | PubMed |
| 7 | 27,125,562 | Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. | Clin Microbiol Infect | 2016 | https://conductscience.org/library/papers/27125562 | PubMed |
| 8 | 20,030,476 | A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin. | Pharmacotherapy | 2010 | https://conductscience.org/library/papers/20030476 | PubMed |
| 9 | 23,235,831 | CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. | Nature | 2013 | https://conductscience.org/library/papers/23235831 | PubMed |
| 10 | 38,136,768 | Adaptive Phage Therapy for the Prevention of Recurrent Nosocomial Pneumonia: Novel Protocol Description and Case Series. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/38136768 | PubMed |
| 11 | 36,671,212 | A Review of Biofilm Formation of Staphylococcus aureus and Its Regulation Mechanism. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36671212 | PubMed |
| 12 | 31,721,069 | Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis. | Curr Osteoporos Rep | 2019 | https://conductscience.org/library/papers/31721069 | PubMed |
| 13 | 10,524,952 | Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. | Clin Infect Dis | 1999 | https://conductscience.org/library/papers/10524952 | PubMed |
| 14 | 39,969,286 | Health benefits, antimicrobial activities, and potential applications of probiotics: A review. | Medicine (Baltimore) | 2024 | https://conductscience.org/library/papers/39969286 | PubMed |
| 15 | 17,517,843 | Experimental phage therapy against Staphylococcus aureus in mice. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17517843 | PubMed |
| 16 | 38,839,974 | Advocating for phage therapy. | Nat Microbiol | 2024 | https://conductscience.org/library/papers/38839974 | PubMed |
| 17 | 6,112,412 | A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. | Lancet | 1981 | https://conductscience.org/library/papers/6112412 | PubMed |
| 18 | 35,414,206 | Lactic acid bacteria and their bacteriocins: new potential weapons in the fight against methicillin-resistant Staphylococcus aureus. | Future Microbiol | 2022 | https://conductscience.org/library/papers/35414206 | PubMed |
| 19 | 20,065,327 | Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. | Clin Microbiol Rev | 2010 | https://conductscience.org/library/papers/20065327 | PubMed |
| 20 | 23,376,548 | Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases. | Immunol Lett | 2013 | https://conductscience.org/library/papers/23376548 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,621,978 | Regenerative Microbiology: Harnessing Bacterial Antagonism and Spatiotemporal Signaling for Diabetic Wound Repair. | Smart Med | 2026 | https://conductscience.org/library/papers/42621978 | PubMed |
| 42,614,264 | A comprehensive review of emerging therapeutic strategies against methicillin-resistant Staphylococcus aureus. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42614264 | PubMed |
| 42,395,635 | Synergistic potential of probiotics and bacteriophages in combating multidrug-resistant microbial infections: A novel therapeutic strategy for the post-antibiotic era. | New Microbes New Infect | 2026 | https://conductscience.org/library/papers/42395635 | PubMed |
| 42,326,420 | Bacteriophage therapy against multidrug resistant bacterial infections demonstrates clinical advances and engineering innovations between 2020-2026. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42326420 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41753631
GET https://conductscience.org/api/papers/v1/41753631/references?page=2